PARP-1 expression correlates with β-catenin levels, and its inhibition has been shown to enhance cisplatin-induced cytotoxicity in cervical cancer cells via the modulation of the β-catenin signaling pathway [28]. Here, PARP1 is linked to cervical cancer.